CRISPR-Cas9 editing in organoids enables disease modeling through gene knockout, correction of patient mutations, and creation of isogenic controls. Applications span cancer driver validation to gene therapy development.
KNOCKOUT
Gene Function
Systematic knockout screens to identify cancer dependencies.
CORRECTION
Gene Therapy
Correct patient mutations to validate therapeutic approaches.